Tag: Biotechnology

incardatherapeutics
United States

InCarda Therapeutics Appoints Dr. Myles Greenberg as New CEO

Press Release – NEWARK, Calif. – December 10, 2024 – InCarda Therapeutics, a clinical stage biopharmaceutical company developing novel therapeutics for cardiac arrythmias, has announced that Myles Greenberg, MD, MBA will serve as its new president and CEO. Dr. Greenberg joins the company as it advances clinical development of its lead product, an orally inhaled treatment for the rapid conversion of recent-onset and symptomatic atrial fibrillation (AF) to sinus … Continue reading InCarda Therapeutics Appoints Dr. Myles Greenberg as New CEO

Impact Newswire
Biotangents
Untied Kingdom

Biotangents Set to Revolutionise Dairy Farming Industry as Investment Round Announced

Press Release – November 28, 2024 – EDINBURGH, Scotland – Technology developed by Scottish biotech Biotangents, which has announced its latest investment round, is set to revolutionise the dairy farming industry with the world’s fastest on-farm, point-of-care diagnostic device aimed at addressing disease in dairy cows. Bovine mastitis alone is estimated to cost the global dairy farming industry around £20 billion every year, costing the average … Continue reading Biotangents Set to Revolutionise Dairy Farming Industry as Investment Round Announced

Impact Newswire
SOPHiA GENETICS
Europe

SOPHiA GENETICS Announces Expanded Partnership with Tennessee Oncology

Press Release – 11/21/2024 Leading community-based practice to utilize increased set of solid tumor applications Boston, MA and Rolle, Switzerland, November 21, 2024 – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a leader in data-driven medicine, announced today that Tennessee Oncology, one of the United States’ largest community-based cancer care specialists that treats nearly half of Tennessee’s cancer patients across 35 clinics, has … Continue reading SOPHiA GENETICS Announces Expanded Partnership with Tennessee Oncology

Impact Newswire
Eikon Therapeutics
United States

Eikon Therapeutics Announces Appointment of Michael Klobuchar as Chief Operating Officer

Press Release – November 20, 2024 – HAYWARD, Calif. – Eikon Therapeutics, Inc., a pioneering biotechnology company that leverages advanced engineering to enhance drug discovery and development, today announced that Michael A. Klobuchar has been appointed Chief Operating Officer. He joins Eikon from Merck & Co. Inc. where he most recently served as Executive Vice President and Chief Strategy Officer. “Mike is an outstanding leader … Continue reading Eikon Therapeutics Announces Appointment of Michael Klobuchar as Chief Operating Officer

Impact Newswire
NUCLIDIUM
Europe

NUCLIDIUM Appoints Tony Rosenberg as Chairman of the Board

Press Release – November 20, 2024 – BASEL, Switzerland – NUCLIDIUM, a clinical-stage radiopharmaceutical company, today announced the appointment of Tony Rosenberg as Chairman of the Board, bringing over 40 years of transformative leadership and industry expertise to the company. “Tony’s appointment marks an exciting new chapter for NUCLIDIUM. His exceptional experience and track record in the biotech and pharma industry will be invaluable as … Continue reading NUCLIDIUM Appoints Tony Rosenberg as Chairman of the Board

Impact Newswire
ArrePath
United States

Kevin Krause named President and CEO of ArrePath

Press Release – November 19, 2024 – PRINCETON, N.J. – ArrePath, Inc., an emerging biotechnology company focused on applying deep phenotypic insights and machine learning to the discovery of new anti-infectives, today announced the appointment of Kevin Krause as President and Chief Executive Officer. Mr. Krause brings more than 25 years of experience in research, clinical development, commercialization, and corporate development in the biotech industry, … Continue reading Kevin Krause named President and CEO of ArrePath

Impact Newswire
Bioptimus
Europe

Bioptimus nomina Mathilda Strom Founding Chief Operating Officer

Press Release – November 14, 2024 – PARIGI – Bioptimus, un’azienda di spicco nel settore dell’intelligenza artificiale che realizza il Foundation Model per la biologia, è entusiasta di annunciare la nomina di Mathilda Strom a Founding Chief Operating Officer. Mathilda entra in Bioptimus con una vasta esperienza nell’espansione di aziende innovative e una reputazione come leader nello sviluppo di organizzazioni a forte impatto in tutto … Continue reading Bioptimus nomina Mathilda Strom Founding Chief Operating Officer

Impact Newswire
VarmX
Europe

VarmX Announces Appointment of John Glasspool as CEO

Leadership team fully strengthened to drive next phase of development LEIDEN, Netherlands – VarmX, a biotech company developing innovative approaches for the bypass of direct oral anticoagulants targeting activated factor Xa (FXa DOACs) and inherited coagulation disorders, has appointed international life sciences industry veteran John Glasspool as CEO, with immediate effect. “I am pleased to be joining the team at VarmX at such an exciting … Continue reading VarmX Announces Appointment of John Glasspool as CEO

Impact Newswire